Antiphospholipid antibodies in predicting adverse pregnancy outcome: A prospective study

Annals of Internal Medicine

Volumn 120, Issue 6, 1994, Pages 470-475

  Lynch, Anne ^a   Marlar, Richard ^b   Murphy, James ^a   Davila, Guillermo ^c   Santos, Michelle ^d   Rutledge, James ^a   Emlen, Woodruff ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c REAADS Medical Products ^*  (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; FETUS WASTAGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0028197405     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-120-6-199403150-00004     Document Type: Article

References (38)

1. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2:1211-4.
2. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990;112:682-98.
3. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 1985;313:152-6.
4. Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellmann D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med. 1987;106:524-31.
5. Lopez LR, Santos ME, Espinoza LR, La Rosa FG. Clinical significance of immunoglobulin A versus immunoglobulins G and M anticardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion. Am J Clin Pathol. 1992;98:449-54.
6. Hull RG, Harris EN, Gharavi AE, Tincani A, Asherson RA, Valesini G, et al. Anticardiolipin antibodies: occurrence in Behcet's syndrome. Ann Rheum Dis. 1984;43,746-8.
7. Keane A, Woods R, Dowding V, Roden D, Barry C. Anticardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol. 1987;26:346-50.
8. Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arth Rheum. 1987;30:752-60.
9. Levine SR, Welch KM. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol. 1987;44:876-83.
10. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol. 1987;69:557-65.
11. Zarrabi MH, Zucker S, Miller F, Derman RM, Romano GS, Hartnett JA, et al. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med. 1979;91:194-9.
12. Mulball BP, Naselli G, Whittingham S. Anticardiolipin antibodies in homosexual men: prevalence and lack of association with human immunodeficiency virus (HIV) infection. J Clin Immunol. 1989;9:208-13.
13. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum. 1991;34:1231-5.
14. Shi W, Krilis SA, Chong BH, Gordon G, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med. 1990;20:231-6.
15. Feinstein DI. Lupus anticoagulant, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood. 1992;80:859-62.
16. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med. 1986;146:2153-6.
17. Lockshin MD, Qamar T, Druzin ML, Goei S. Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumtol. 1987;14:259-61.
18. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol. 1989;16:482-8.
19. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol. 1991;49: 193-280.
20. Laskin CA, Soloninka CA. Anticardiolipin antibodies: smoking gun or smoke screen? J Rheumatol. 1988;15:7-9.
21. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol. 1989;161:369-73.
22. Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol. 1991;165:1272-7.
23. Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med. 1991;325:1063-6.
24. Robinson RD, McGlasson GL. Evidence of antiphospholipid antibodies in an obstetric population. Fifth International Symposium on Antiphospholipid Antibodies. September 9-12, 1992, San Antonio, Texas.
25. Polzin WJ, Kopelman JN, Robinson RD, Read JA, Brady K. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol. 1991;78:1108-11.
26. Brown HL, Perez MC, Wilson W, Scopelitis E. Anticardiolipin antibodies in an unselected obstetric population: relationship to fetal outcome. Abstract 272. Society of Perinatal Obstetricians, Tenth Annual Meeting, January 23-27, 1990.
27. Gabbe SG, Niebyl JR, Simpson JL, Anderson GD, eds. Obstetrics: Normal and Problem Pregnancies. New York: Churchill Livingstone; 1986.
28. Bonnar J. Acute and chronic coagulation problems in pregnancy. In: Poller L, ed. Recent Advances in Blood Coagulation. Edinburgh: Churchill Livingstone; 1977:363-78.
29. Triplett DA. Antiphospholipid antibodies and recurrent pregnancy loss. Am J Reprod Immunol. 1989;20:52-67.
30. Tate G, Scott JS. Detection of lupus anticoagulant in stored serum [Letter]. Lancet. 1984;2:587.
31. Out HJ, Bruinse HW, Christiaens GC, van Vieit M, de Groot PG, Nieuwenhuis HK, et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol. 1992;167:26-32.
32. Branch DW, Dudley DJ, Mitchell MD, Creighton KA, Abbott TM, Hammond EH, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol. 1990;163:210-6.
33. Lockshin MD, Letendre CH. Antiphospholipid antibody/lupus anticoagulant workshop. Arthritis Rheum. 1992;35:1234-7.
34. Rote NS, Walter A, Lyden TW. Antiphospholipid antibodies - lobsters or red herrings? Am J Reprod Immunol. 1992;28:31-7.
35. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol. 1989;73:541-5.
36. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990;87:4120-4.
37. Galli M, Comfurius P, Maassen C, Hemker HC, de Beets MH, van Breda-Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990;335:1544-7.
38. Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost. 1989;62:892-6.